You are here:

Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy.

Stokkevåg CH et al. Radiother Oncol. 2016 Aug;120(2):300-6.

Stokkevåg CH, Fukahori M, Nomiya T, Matsufuji N, Engeseth GM, Hysing LB, Ytre-Hauge KS, Rørvik E, Szostak A, Muren LP.
Radiotherapy and Oncology
Radiother Oncol. 2016 Aug;120(2):300-6.